| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Department of Microbiology and Immunology and
William K. Warren Medical Research Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190
Therapies to elicit protective CTL require the selection of pathogen- and tumor-derived peptide ligands for presentation by MHC class I molecules. Edman sequencing of class I peptide pools generates "motifs" that indicate that nonameric ligands bearing conserved position 2 (P2) and P9 anchors provide the optimal search parameters for selecting immunogenic epitopes. To determine how well a motif represents its individual constituents, we used a hollow-fiber peptide production scheme followed by the mapping of endogenously processed class I peptide ligands through reverse-phase HPLC and mass spectrometry. Systematically mapping and characterizing ligands from B*1508, B*1501, B*1503, and B*1510 demonstrate that the peptides bound by these B15 allotypes i) vary in length from 7 to 12 residues, and ii) are more conserved at their C termini than their N-proximal P2 anchors. Comparative peptide mapping of these B15 allotypes further pinpoints endogenously processed ligands that bind to the allotypes B*1508, B*1501, and B*1503, but not B*1510. Overlapping peptide ligands are successful in binding to B*1501, B*1503, and B*1508 because these B15 allotypes share identical C-terminal anchoring pockets whereas B*1510 is divergent in the C-terminal pocket. Therefore, endogenous peptide loading into the B15 allotypes requires that a conserved C terminus be anchored in the appropriate specificity pocket while N-proximal anchors are more flexible in their location and sequence. Queries for overlapping and allele-specific peptide ligands may thus be contingent on a conserved C-terminal anchor.
This article has been cited by other articles:
|
|
 |
|
  H. Escobar, D. K. Crockett, E. Reyes-Vargas, A. Baena, A. L. Rockwood, P. E. Jensen, and J. C. Delgado Large Scale Mass Spectrometric Profiling of Peptides Eluted from HLA Molecules Reveals N-Terminal-Extended Peptide Motifs J. Immunol., October 1, 2008; 181(7): 4874 - 4882. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes PNAS, February 26, 2008; 105(8): 2981 - 2986.
|
|
|
|
|
|
J. T. Loffredo, J. Sidney, S. Piaskowski, A. Szymanski, J. Furlott, R. Rudersdorf, J. Reed, B. Peters, H. D. Hickman-Miller, W. Bardet, et al. The High Frequency Indian Rhesus Macaque MHC Class I Molecule, Mamu-B*01, Does Not Appear to Be Involved in CD8+ T Lymphocyte Responses to SIVmac239 J. Immunol., November 1, 2005; 175(9): 5986 - 5997. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Frahm, S. Adams, P. Kiepiela, C. H. Linde, H. S. Hewitt, M. Lichterfeld, K. Sango, N. V. Brown, E. Pae, A. G. Wurcel, et al. HLA-B63 Presents HLA-B57/B58-Restricted Cytotoxic T-Lymphocyte Epitopes and Is Associated with Low Human Immunodeficiency Virus Load J. Virol., August 15, 2005; 79(16): 10218 - 10225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. W. Purcell and J. J. Gorman Immunoproteomics: Mass Spectrometry-based Methods to Study the Targets of the Immune Response Mol. Cell. Proteomics, March 1, 2004; 3(3): 193 - 208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Turnquist, J. L. Petersen, S. E. Vargas, M. M. McIlhaney, E. Bedows, W. E. Mayer, A. G. Grandea III, L. Van Kaer, and J. C. Solheim The Ig-Like Domain of Tapasin Influences Intermolecular Interactions J. Immunol., March 1, 2004; 172(5): 2976 - 2984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Macdonald, A. W. Purcell, N. A. Mifsud, L. K. Ely, D. S. Williams, L. Chang, J. J. Gorman, C. S. Clements, L. Kjer-Nielsen, D. M. Koelle, et al. A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition J. Exp. Med., September 2, 2003; 198(5): 679 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D. Hickman, A. D. Luis, W. Bardet, R. Buchli, C. L. Battson, M. H. Shearer, K. W. Jackson, R. C. Kennedy, and W. H. Hildebrand Cutting Edge: Class I Presentation of Host Peptides Following HIV Infection J. Immunol., July 1, 2003; 171(1): 22 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Admon, E. Barnea, and T. Ziv Tumor Antigens and Proteomics from the Point of View of the Major Histocompatibility Complex Peptides Mol. Cell. Proteomics, June 1, 2003; 2(6): 388 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. R. Turnquist, S. E. Vargas, A. J. Reber, M. M. McIlhaney, S. Li, P. Wang, S. D. Sanderson, B. Gubler, P. van Endert, and J. C. Solheim A Region of Tapasin That Affects Ld Binding and Assembly J. Immunol., October 15, 2001; 167(8): 4443 - 4449. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Novitsky, N. Rybak, M. F. McLane, P. Gilbert, P. Chigwedere, I. Klein, S. Gaolekwe, S. Y. Chang, T. Peter, I. Thior, et al. Identification of Human Immunodeficiency Virus Type 1 Subtype C Gag-, Tat-, Rev-, and Nef-Specific Elispot-Based Cytotoxic T-Lymphocyte Responses for AIDS Vaccine Design J. Virol., October 1, 2001; 75(19): 9210 - 9228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Urvater, H. Hickman, J. L. Dzuris, K. Prilliman, T. M. Allen, K. J. Schwartz, D. Lorentzen, C. Shufflebotham, E. J. Collins, D. L. Neiffer, et al. Gorillas with Spondyloarthropathies Express an MHC Class I Molecule with Only Limited Sequence Similarity to HLA-B27 that Binds Peptides with Arginine at P2 J. Immunol., March 1, 2001; 166(5): 3334 - 3344. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
